Prevention for LongevityInstitutionIntelligenceStandardWorkAboutDiscuss an opportunity
P4LPrevention for LongevityEvidence → Decision → Adoption

Public Proof Ledger · CLM-0008

FDA announced a funding opportunity that was open from July 20 through August 20, 2026, for projects exploring digital health technologies in drug development, including actigraphy, photography, and contactless sensors. The application window is closed. P4L is now watching for awardees, selected modalities, endpoint methods, validation work, and resulting guidance or precedents.

Sourced factHistoricalPrimary/authoritativev1.0

Provenance

First verified
2026-07-23
Source updated
2026-08-20
Last verified
2026-09-03
Status
Historical · application window closed
Freshness
Historical
Version
1.0
Fingerprint
1c2e03fbf7cfdb63
Change sensitivity
High

Evidence limits

A historical funding opportunity does not establish an award, a validated digital measure, regulatory endpoint acceptance, guidance, or clinical benefit.

For this decision

Researchers · Innovators · Funders/investors · Policymakers · Clinicians

Primary source

https://www.fda.gov/science-research/science-and-research-special-topics/digital-health-technologies-dhts-drug-development

Related signals